Robert D. Christensen

Robert D. Christensen

Auto-generated profile, based on publicly available information

Robert D. Christensen

Division of Neonatology, Department of Pediatrics, University of Utah Health, Salt Lake City, USA

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2015 in Pediatrics
Verified
Journal Article
Closed access
PDF file
RCRobert D. Christensen
Robert D. Christensen
HYHassan M. Yaish
Hassan M. Yaish
PGPatrick G. Gallagher
Patrick G. Gallagher
Newborn infants who have hereditary spherocytosis (HS) can develop anemia and hyperbilirubinemia. Bilirubin-induced neurologic dysfunction is less likely in these neonates if the diagnosis of HS is recognized and appropriate treatment provided. Among neonates listed in the USA Kernicterus Registry, HS was the third most common underlying hemolytic condition after glucose-6-phosphate dehydrogenase deficiency and ABO hemolytic disease. HS is the leading cause of direct antiglobulin test (direct Coombs) negative hemolytic anemia requiring erythrocyte transfusion in the first months of life. We anticipate that as physicians become more familiar with diagnosing HS in the newborn period, fewer neonates with HS will develop hazardous hyperbilirubinemia or present to emergency departments with unanticipated symptomatic anemia. We predict that early suspicion, prompt diagnosis and treatment, and anticipatory guidance will prevent adverse outcomes in neonates with HS. The purpose of this article was to review the neonatal presentation of HS and to provide practical and up-to-date means of diagnosing and treating HS in neonates.

1 November 2015 in Pediatrics
Verified
Journal Article
Open access
PDF file
RCRobert D. Christensen
Robert D. Christensen
BYBradley A. Yoder
Bradley A. Yoder
VBVickie L. Baer
Vickie L. Baer
GSGregory Laird Snow
Gregory Laird Snow
ABAllison Butler
Allison Butler
BACKGROUND: Early neutropenia is more common in small for gestational age (SGA) neonates (birth weight <10th percentile) than in appropriately grown neonates. However, several aspects of this variety of neutropenia are unknown, including the duration, kinetic mechanism, and outcomes. METHODS: Using 10 years of multihospital records, we studied SGA neonates who, during the first week after birth, had neutrophil counts <1000/μL. RESULTS: This degree of neutropenia was more common in SGA neonates (6%, 207/3650) than in non-SGA matched controls (1%, 46/3650; P < .001). Neutrophil counts stayed below the lower reference interval for 7 days. Ratios of immature to total neutrophils were within the reference interval, suggesting reduced neutrophil production, not accelerated neutrophil use or destruction. Increased nucleated red cells at birth correlated with decreased neutrophils (P < .001). Neutropenia was not independently associated with maternal hypertensive disorders, over and above the effect of SGA. Of 201 neutropenic SGA neonates, 129 (64%) also had thrombocytopenia. Sixteen percent of neutropenic neonates were treated with recombinant granulocyte colony-stimulating factor (rG-CSF) or intravenous immunoglobulin (IVIG), with no reduction in late-onset sepsis or necrotizing enterocolitis (NEC). Regression analysis showed that neutropenia (but not thrombocytopenia in the absence of neutropenia) was independently associated with increased odds of developing necrotizing enterocolitis (odds ratio 4.01, 90% confidence interval 2.08 to 7.35, P < .001). CONCLUSIONS: Neutropenia of SGA is a condition of 1-week duration. It is more closely associated with SGA than maternal hypertension (likely owing to neutrophil hypoproduction associated with intrauterine hypoxia), often accompanied by thrombocytopenia, not obviously improved by rG-CSF or IVIG, and associated with an increased risk for NEC.

21 April 2009 in Transfusion
Verified
Journal Article
Closed access
PDF file
MDM. Lynn Dohner
M. Lynn Dohner
SWSusan E. Wiedmeier
Susan E. Wiedmeier
RSRonald A. Stoddard
Ronald A. Stoddard
DNDonald Null
Donald Null
DLDiane K. Lambert
Diane K. Lambert
RCRobert D. Christensen
Robert D. Christensen

1 August 2015 in Pediatrics
Verified
Journal Article
Closed access
PDF file
RCRobert D. Christensen
Robert D. Christensen
VBVickie L. Baer
Vickie L. Baer
EHErick Henry
Erick Henry
GSGregory Laird Snow
Gregory Laird Snow
ABAllison Butler
Allison Butler
MSMartha C. Sola-Visner
Martha C. Sola-Visner
BACKGROUND: Thrombocytopenia is common among small-for-gestational-age (SGA) neonates (birth weight <10th percentile reference range), but several aspects of this thrombocytopenia are unclear, including the incidence, typical nadir, duration, association with preeclampsia, mechanism, and risk of death. METHODS: Using 9 years of multihospital records, we studied SGA neonates with ≥2 platelet counts <150 000/μL in their first week. RESULTS: We found first-week thrombocytopenia in 31% (905 of 2891) of SGA neonates versus 10% of non-SGA matched controls (P < .0001). Of the 905, 102 had a recognized cause of thrombocytopenia (disseminated intravascular coagulation, early-onset sepsis, or extracorporeal membrane oxygenation). This group had a 65% mortality rate. The remaining 803 did not have an obvious cause for their thrombocytopenia, and we called this “thrombocytopenia of SGA.” They had a mortality rate of 2% (P < .0001) and a mean nadir count on day 4 of 93 000/μL (SD 51 580/μL, 10th percentile 50 000/μL, 90th percentile 175 000/μL). By day 14, platelet counts were ≥150 000/μL in more than half of the patients. Severely SGA neonates (<1st percentile) had lower counts and longer thrombocytopenia duration (P < .001). High nucleated red cell counts at birth correlated with low platelets (P < .0001). Platelet transfusions were given to 23%, and counts typically more than tripled. Thrombocytopenia was more associated with SGA status than with the diagnosis of maternal preeclampsia. CONCLUSIONS: SGA neonates with clearly recognized varieties of thrombocytopenia have a high mortality rate. In contrast, thrombocytopenia of SGA is a hyporegenerative condition of moderate severity and 2 weeks’ duration and is associated with evidence of intrauterine hypoxia and a low mortality rate.

16 June 2015 in Maternal Health, Neonatology and Perinatology
Verified
Journal Article
Open access
PDF file
PCPatrick D. Carroll
Patrick D. Carroll
RCRobert D. Christensen
Robert D. Christensen
In an era increasingly focused on quality improvement and cost containment, more emphasis is being placed on wiser utilization of medical care resources. One underutilized resource in early neonatal care is umbilical cord blood. Umbilical cord blood can be utilized for admission laboratory studies in neonates thereby avoiding a significant phlebotomy event in the first minutes to hours of life. Additionally, umbilical cord blood can also be safely “transfused” into the neonate via delayed cord clamping or milking of the umbilical cord. This has been demonstrated to be particularly beneficial in premature infants by decreasing the rate of intraventricular hemorrhage. Delayed cord clamping has been formally endorsed by a number of medical societies, however it has not yet been universally adopted by obstetricians and neonatologists. Both uses of umbilical cord blood for neonatal admission laboratory testing and delayed cord clamping/milking of the umbilical cord have resulted in decreased transfusion rates as well as other outcomes reviewed herein.

1 September 2015 in Clinics in Perinatology
Verified
Journal Article
Closed access
RCRobert D. Christensen
Robert D. Christensen
HYHassan M. Yaish
Hassan M. Yaish